These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Identification of an early activation antigen (Bac-1) on human B cells. Suzuki T, Sanders SK, Butler JL, Gartland GL, Komiyama K, Cooper MD. J Immunol; 1986 Aug 15; 137(4):1208-13. PubMed ID: 3090143 [Abstract] [Full Text] [Related]
8. Isotype commitment of human B cells that are transformed by Epstein-Barr virus. Miyawaki T, Butler JL, Radbruch A, Gartland GL, Cooper MD. Eur J Immunol; 1991 Jan 15; 21(1):215-20. PubMed ID: 1846818 [Abstract] [Full Text] [Related]
9. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells. Ehlin-Henriksson B, Mowafi F, Klein G, Nilsson A. Immunology; 2006 Mar 15; 117(3):379-85. PubMed ID: 16476057 [Abstract] [Full Text] [Related]
11. Ig isotypes produced by EBV-transformed B cells as a function of age and tissue distribution. Miyawaki T, Kubagawa H, Butler JL, Cooper MD. J Immunol; 1988 Jun 01; 140(11):3887-92. PubMed ID: 2836502 [Abstract] [Full Text] [Related]
12. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas. Yokochi T, Holly RD, Clark EA. J Immunol; 1982 Feb 01; 128(2):823-7. PubMed ID: 6274961 [Abstract] [Full Text] [Related]
13. Antigen presentation by human B cells: T cell proliferation induced by Epstein Barr virus B lymphoblastoid cells. Issekutz T, Chu E, Geha RS. J Immunol; 1982 Oct 01; 129(4):1446-50. PubMed ID: 6286767 [Abstract] [Full Text] [Related]
14. In vitro regulation of IgA subclass production. III. Selective transformation of IgA1 producing cells by Epstein-Barr virus. Conley ME, Chan MA, Sigal NH. J Immunol; 1987 Mar 01; 138(5):1403-7. PubMed ID: 3027178 [Abstract] [Full Text] [Related]
15. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes. Nemerow GR, McNaughton ME, Cooper NR. J Immunol; 1985 Nov 01; 135(5):3068-73. PubMed ID: 2995485 [Abstract] [Full Text] [Related]
16. Suppressive effect of human natural killer cells on Epstein-Barr virus-induced immunoglobulin synthesis. Kuwano K, Arai S, Munakata T, Tomita Y, Yoshitake Y, Kumagai K. J Immunol; 1986 Sep 01; 137(5):1462-8. PubMed ID: 3018077 [Abstract] [Full Text] [Related]
18. Relative lack of Epstein Barr virus (EBV) receptors on B cells from persistently EBV seronegative adults. Gervais F, Wills A, Leyritz M, Lebrun A, Joncas JH. J Immunol; 1981 Mar 01; 126(3):897-900. PubMed ID: 6257786 [Abstract] [Full Text] [Related]
19. The A-myb gene is preferentially expressed in tonsillar CD38+, CD39-, and sIgM- B lymphocytes and in Burkitt's lymphoma cell lines. Golay J, Erba E, Bernasconi S, Peri G, Introna M. J Immunol; 1994 Jul 15; 153(2):543-53. PubMed ID: 8021494 [Abstract] [Full Text] [Related]
20. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells]. Koizumi S. Hokkaido Igaku Zasshi; 1985 Sep 15; 60(5):724-34. PubMed ID: 3000906 [Abstract] [Full Text] [Related] Page: [Next] [New Search]